Search

Board Moves October 28, 2019

AusCann Group Holdings has announced changes to its board as it progresses towards the next stage of growth and development as a cannabinoid-focused pharmaceutical company.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Source: Morningstar

Total Shareholder Return as at 31/10/19

1 year TSR5 year TSR
104thRBR Group75%1%
207thBARD1 Life Sciences30%16%
767thAusCann Group Holdings-61%49%
730 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

08/03/19
$11k Bought
07/03/19
$47k Bought
09/08/18
$15k Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

150th↓Grandbridge$703k
151st↑AusCann Group Holdings$671k
153rd↑BARD1 Life Sciences$571k
154th↓RBR Group$530k
197 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer